Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Challenges in Establishing Pure Lung Cancer Organoids Limit Their Utility for Personalized Medicine
Krijn K. Dijkstra, Kim Monkhorst, Luuk J. Schipper, et al.
Cell Reports (2020) Vol. 31, Iss. 5, pp. 107588-107588
Open Access | Times Cited: 193

Showing 26-50 of 193 citing articles:

Standardization of organoid culture in cancer research
Changchun Zhou, Yuanbo Wu, Zeyu Wang, et al.
Cancer Medicine (2023) Vol. 12, Iss. 13, pp. 14375-14386
Open Access | Times Cited: 35
Converging bioprinting and organoids to better recapitulate the tumor microenvironment
Xiaoyu Wang, Yixue Luo, Yuankai Ma, et al.
Trends in biotechnology (2023) Vol. 42, Iss. 5, pp. 648-663
Open Access | Times Cited: 28
The application of patient-derived organoid in the research of lung cancer
Yin Li, Xinyu Gao, Chao Ni, et al.
Cellular Oncology (2023) Vol. 46, Iss. 3, pp. 503-519
Open Access | Times Cited: 26
Bioprinting of Cells, Organoids and Organs-on-a-Chip Together with Hydrogels Improves Structural and Mechanical Cues
Claudia Tanja Mierke
Cells (2024) Vol. 13, Iss. 19, pp. 1638-1638
Open Access | Times Cited: 9
Long-term maintenance of patient-specific characteristics in tumoroids from six cancer indications
Colin D. Paul, Chris Yankaskas, Pradip Shahi Thakuri, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Genomic characteristics and drug screening among organoids derived from non‐small cell lung cancer patients
Jing‐Hua Chen, Xiang‐Peng Chu, Jia‐Tao Zhang, et al.
Thoracic Cancer (2020) Vol. 11, Iss. 8, pp. 2279-2290
Open Access | Times Cited: 56
Research Progress, Challenges, and Breakthroughs of Organoids as Disease Models
Yisheng Huang, Zhijie Huang, Zhengming Tang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 56
Recent advances in preclinical models for lung squamous cell carcinoma
Yuanwang Pan, Han Han, Kristen Labbe, et al.
Oncogene (2021) Vol. 40, Iss. 16, pp. 2817-2829
Closed Access | Times Cited: 46
Progress towards non-small-cell lung cancer models that represent clinical evolutionary trajectories
Robert E. Hynds, Kristopher K. Frese, David R. Pearce, et al.
Open Biology (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 44
Mesenchymal tumor organoid models recapitulate rhabdomyosarcoma subtypes
Michael T. Meister, Marian J.A. Groot Koerkamp, Terezinha de Souza, et al.
EMBO Molecular Medicine (2022) Vol. 14, Iss. 10
Open Access | Times Cited: 38
OrBITS: label-free and time-lapse monitoring of patient derived organoids for advanced drug screening
Christophe Deben, Edgar Cardenas De La Hoz, Maxim Le Compte, et al.
Cellular Oncology (2022) Vol. 46, Iss. 2, pp. 299-314
Open Access | Times Cited: 38
Technologies to Assess Drug Response and Heterogeneity in Patient-Derived Cancer Organoids
Melissa C. Skala, Dustin A. Deming, Jeremy D. Kratz
Annual Review of Biomedical Engineering (2022) Vol. 24, Iss. 1, pp. 157-177
Open Access | Times Cited: 33
Microbiome as an immune regulator in health, disease, and therapeutics
Valeria M. Juarez, Alyssa N. Montalbine, Ankur Singh
Advanced Drug Delivery Reviews (2022) Vol. 188, pp. 114400-114400
Open Access | Times Cited: 29
Exploring Tumor–Immune Interactions in Co-Culture Models of T Cells and Tumor Organoids Derived from Patients
S.Y. Jeong, Minyong Kang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14609-14609
Open Access | Times Cited: 22
Organoids in high-throughput and high-content screenings
Franziska L. Lampart, Dagmar Iber, Nikolaos Doumpas
Frontiers in Chemical Engineering (2023) Vol. 5
Open Access | Times Cited: 20
Cancer organoids: A platform in basic and translational research
Xin Ma, Qin Wang, Guozheng Li, et al.
Genes & Diseases (2023) Vol. 11, Iss. 2, pp. 614-632
Open Access | Times Cited: 20
Organoids: opportunities and challenges of cancer therapy
Xianjie Jiang, Linda Oyang, Peng Qiu, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 19
Cryobiopsy: A Breakthrough Strategy for Clinical Utilization of Lung Cancer Organoids
Dongil Park, Dahye Lee, Yoonjoo Kim, et al.
Cells (2023) Vol. 12, Iss. 14, pp. 1854-1854
Open Access | Times Cited: 18
Ex vivo drug testing of patient-derived lung organoids to predict treatment responses for personalized medicine
Josephine A. Taverna, Chia‐Nung Hung, Madison Williams, et al.
Lung Cancer (2024) Vol. 190, pp. 107533-107533
Open Access | Times Cited: 8
Toward reproducible tumor organoid culture: focusing on primary liver cancer
Lianming Guo, Chao Li, Weiqiang Gong
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Assessing personalized responses to anti-PD-1 treatment using patient-derived lung tumor-on-chip
Irina Veith, Martin Nurmik, Arianna Mencattini, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 5, pp. 101549-101549
Open Access | Times Cited: 8
Organoid-based personalized medicine: from tumor outcome prediction to autologous transplantation
Abel Soto-Gamez, Jeremy Putra Gunawan, Lara Barazzuol, et al.
Stem Cells (2024) Vol. 42, Iss. 6, pp. 499-508
Open Access | Times Cited: 7
Human pluripotent stem cell‐derived lung organoids: Potential applications in development and disease modeling
Lü Tian, Jinghui Gao, Irving M. Garcia, et al.
Wiley Interdisciplinary Reviews Developmental Biology (2020) Vol. 10, Iss. 6
Closed Access | Times Cited: 40
Lung organoids: advances in generation and 3D-visualization
Brian Cunniff, Joseph E. Druso, Jos van der Velden
Histochemistry and Cell Biology (2021) Vol. 155, Iss. 2, pp. 301-308
Open Access | Times Cited: 38
EHMT1 knockdown induces apoptosis and cell cycle arrest in lung cancer cells by increasing CDKN1A expression
Jin‐Kwon Lee, Kwang‐Ho Kim, Tae Young Ryu, et al.
Molecular Oncology (2021) Vol. 15, Iss. 11, pp. 2989-3002
Open Access | Times Cited: 36

Scroll to top